Global Postpartum Hemorrhage Treatment Device Market by Type (Uterine Balloon Tamponade, Uniject Prefilled Injection System, Other), By Application (Hospitals, Clinics, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
The Global Postpartum Hemorrhage Treatment Device Market size is projected to grow at a CAGR of 8.0% during the forecast period, to reach a revenue of $2.3 billion by 2028 from $1.6 billion in 2017, with an emergence of new product launches and clinical trials driving this growth. The most significant drivers for this growth are the increasing number of deliveries globally and growing awareness about postpartum hemorrhage among women and gynecologists.
Postpartum Hemorrhage Treatment Device can be defined as devices that can be used to stop bleeding after delivery. It may be inserted into the uterus or injected directly into the uterine cavity through an intra-uterine injection system, balloon tamponade, and other methods.
On the basis of Types, the market is segmented into Uterine Balloon Tamponade, Uniject Prefilled Injection System, and Other.
Uterine Balloon Tamponade:
Uterine Balloon Tamponade is a type of device that is used to control postpartum hemorrhage by inflating an intrauterine balloon during the delivery process. These devices are recommended for controlling heavy bleeding and uterine atony, which can cause uterine rupture or other complications.
Uterine Balloon Tamponade is mainly used in the management of postpartum hemorrhage. Other potential applications include: treating uterine atony following a cesarean delivery, which may cause rupture and other complications; to control heavy bleeding with minimal risks during labor or cesarean surgery: for recurrent miscarriage, where it can be inserted if there is an incomplete evacuation after a spontaneous abortion.
Uniject Prefilled Injection System:
Uniject is a pre-filled injection system of oxytocin (a hormone) that can be used in the management of postpartum hemorrhage or uterine atony. The fluid within Uniject has been designed to be delivered by needleless syringe dispensing technology and reconstituted with sterile normal saline, so it does not need to be administered using an infusion pump. It comes as either single-dose vials for emergency use or more commonly, as autoinjection systems which allow up to three doses from one package.
On the basis of Application, the market is segmented into Hospitals, Clinics, and Others.
Hospitals:
Hospitals will be the largest application segment in this market. They are used to monitor and treat postpartum hemorrhage, a condition where bleeding occurs after childbirth that can lead to death if not treated immediately. Hospitals or clinics use these devices for the treatment of severe cases of postpartum hemorrhage when uterine balloon tamponade and Uniject Prefilled Injection System do not work effectively. These hospitals have specialized obstetric units with skilled professionals who provide care for women during pregnancy, delivery, as well as assessments for complications following birth which may include postpartum hemorrhaging
Clinics:
Clinics constitute a smaller share than hospitals but important due to their proximity in rural areas. There is an increasing trend in the number of clinics providing postpartum hemorrhage treatment, which is likely to continue due to the shortage of hospitals with obstetric units and skilled personnel.
On the basis of Region, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is one of the fastest-growing markets in this region due to a number of factors such as increasing incidence rates for postpartum hemorrhage complications, technological advancements in the healthcare industry with an emphasis on improving end-user experience; and expansion plans by key players like CareFusion Corporation (Uterine Balloon Tamponade), GlaxoSmithKline plc (Uniject Prefilled Injection System).
Growth Factors For The Global Postpartum Hemorrhage Treatment Device Market:
- The increasing prevalence of postpartum hemorrhage disorders is driving the demand for the global postpartum hemorrhage treatment device market.
- The rising need to control bleeding during and after delivery has been identified as one of the major factors expected to have a positive impact on this market in the coming years.
- An inadequate number of qualified staff available in remote areas also drives the growth in demand for devices that can be easily used by untrained personnel, such as uterine balloon tamponade and Uniject Prefilled Injection System Postpartum Hemorrhage Treatment Devices markets.
Up Market Research published a new report titled “Postpartum Hemorrhage Treatment Device Market research report which is segmented by Types (Uterine Balloon Tamponade, Uniject Prefilled Injection System, Other), By Applications (Hospitals, Clinics, Other), By Players/Companies Bactiguard, R. Bard, Cook Medical, Davol, 3rd Stone Design, Teleflexorporated, Utah Medical Products, Becton Dickinson, Ge Healthcare, Inpress Technologies, Zoex Niasg”.
Report Scope
| Report Attributes | Report Details |
| Report Title | Postpartum Hemorrhage Treatment Device Market Research Report |
| By Type | Uterine Balloon Tamponade, Uniject Prefilled Injection System, Other |
| By Application | Hospitals, Clinics, Other |
| By Companies | Bactiguard, R. Bard, Cook Medical, Davol, 3rd Stone Design, Teleflexorporated, Utah Medical Products, Becton Dickinson, Ge Healthcare, Inpress Technologies, Zoex Niasg |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 231 |
| Number of Tables & Figures | 162 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Postpartum Hemorrhage Treatment Device Market Report Segments:
The market is segmented by Type Uterine Balloon Tamponade, Uniject Prefilled Injection System, Other and By Application Hospitals, Clinics, Other.
Some of the companies that are profiled in this report are:
- Bactiguard
- R. Bard
- Cook Medical
- Davol
- 3rd Stone Design
- Teleflexorporated
- Utah Medical Products
- Becton Dickinson
- Ge Healthcare
- Inpress Technologies
- Zoex Niasg
Postpartum Hemorrhage Treatment Device Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Postpartum Hemorrhage Treatment Device Market
Overview of the regional outlook of the Postpartum Hemorrhage Treatment Device Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Postpartum Hemorrhage Treatment Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Postpartum Hemorrhage Treatment Device Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
- By Type:
1. Uterine Balloon Tamponade
2. Uniject Prefilled Injection System
3. Other
7. By Application:1. Hospitals
2. Clinics
3. Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Postpartum Hemorrhage Treatment Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Postpartum Hemorrhage Treatment Device Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Postpartum Hemorrhage Treatment Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Postpartum Hemorrhage Treatment Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Postpartum Hemorrhage Treatment Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Postpartum Hemorrhage Treatment Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Postpartum Hemorrhage Treatment Device Market Size & Forecast, 2018-2028
4.5.1 Postpartum Hemorrhage Treatment Device Market Size and Y-o-Y Growth
4.5.2 Postpartum Hemorrhage Treatment Device Market Absolute $ Opportunity
Chapter 5 Global Postpartum Hemorrhage Treatment Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
5.2.1 Uterine Balloon Tamponade
5.2.2 Uniject Prefilled Injection System
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Postpartum Hemorrhage Treatment Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Postpartum Hemorrhage Treatment Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Postpartum Hemorrhage Treatment Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Postpartum Hemorrhage Treatment Device Analysis and Forecast
9.1 Introduction
9.2 North America Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
9.6.1 Uterine Balloon Tamponade
9.6.2 Uniject Prefilled Injection System
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Postpartum Hemorrhage Treatment Device Analysis and Forecast
10.1 Introduction
10.2 Europe Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
10.6.1 Uterine Balloon Tamponade
10.6.2 Uniject Prefilled Injection System
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Postpartum Hemorrhage Treatment Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
11.6.1 Uterine Balloon Tamponade
11.6.2 Uniject Prefilled Injection System
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Postpartum Hemorrhage Treatment Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
12.6.1 Uterine Balloon Tamponade
12.6.2 Uniject Prefilled Injection System
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Postpartum Hemorrhage Treatment Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
13.6.1 Uterine Balloon Tamponade
13.6.2 Uniject Prefilled Injection System
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Postpartum Hemorrhage Treatment Device Market: Competitive Dashboard
14.2 Global Postpartum Hemorrhage Treatment Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bactiguard
14.3.2 R. Bard
14.3.3 Cook Medical
14.3.4 Davol
14.3.5 3rd Stone Design
14.3.6 Teleflexorporated
14.3.7 Utah Medical Products
14.3.8 Becton Dickinson
14.3.9 Ge Healthcare
14.3.10 Inpress Technologies
14.3.11 Zoex Niasg
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Postpartum Hemorrhage Treatment Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Postpartum Hemorrhage Treatment Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Postpartum Hemorrhage Treatment Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Postpartum Hemorrhage Treatment Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Postpartum Hemorrhage Treatment Device Market Size & Forecast, 2018-2028
4.5.1 Postpartum Hemorrhage Treatment Device Market Size and Y-o-Y Growth
4.5.2 Postpartum Hemorrhage Treatment Device Market Absolute $ Opportunity
Chapter 5 Global Postpartum Hemorrhage Treatment Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
5.2.1 Uterine Balloon Tamponade
5.2.2 Uniject Prefilled Injection System
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Postpartum Hemorrhage Treatment Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Postpartum Hemorrhage Treatment Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Postpartum Hemorrhage Treatment Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Postpartum Hemorrhage Treatment Device Analysis and Forecast
9.1 Introduction
9.2 North America Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
9.6.1 Uterine Balloon Tamponade
9.6.2 Uniject Prefilled Injection System
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Postpartum Hemorrhage Treatment Device Analysis and Forecast
10.1 Introduction
10.2 Europe Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
10.6.1 Uterine Balloon Tamponade
10.6.2 Uniject Prefilled Injection System
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Postpartum Hemorrhage Treatment Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
11.6.1 Uterine Balloon Tamponade
11.6.2 Uniject Prefilled Injection System
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Postpartum Hemorrhage Treatment Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
12.6.1 Uterine Balloon Tamponade
12.6.2 Uniject Prefilled Injection System
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Postpartum Hemorrhage Treatment Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Postpartum Hemorrhage Treatment Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Postpartum Hemorrhage Treatment Device Market Size Forecast by Type
13.6.1 Uterine Balloon Tamponade
13.6.2 Uniject Prefilled Injection System
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Postpartum Hemorrhage Treatment Device Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Postpartum Hemorrhage Treatment Device Market: Competitive Dashboard
14.2 Global Postpartum Hemorrhage Treatment Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bactiguard
14.3.2 R. Bard
14.3.3 Cook Medical
14.3.4 Davol
14.3.5 3rd Stone Design
14.3.6 Teleflexorporated
14.3.7 Utah Medical Products
14.3.8 Becton Dickinson
14.3.9 Ge Healthcare
14.3.10 Inpress Technologies
14.3.11 Zoex Niasg
Segments Covered in the Report
The global Postpartum Hemorrhage Treatment Device market has been segmented based on
By Types
The global Postpartum Hemorrhage Treatment Device market has been segmented based on
By Types
- Uterine Balloon Tamponade
- Uniject Prefilled Injection System
- Other
- Hospitals
- Clinics
- Other
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Bactiguard
- R. Bard
- Cook Medical
- Davol
- 3rd Stone Design
- Teleflexorporated
- Utah Medical Products
- Becton Dickinson
- Ge Healthcare
- Inpress Technologies
- Zoex Niasg
Our Clients
Related Reports
Some other reports from this category!
